LWM
ABBV icon

LeConte Wealth Management’s AbbVie ABBV Stock Holding History

LeConte Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
7,173
+4,686
+188% +$1.04M 1.01% 21
2025
Q4 		$568K Sell
2,487
-24
-1% -$5.47K 0.37% 40
2025
Q3 		$581K Buy
2,511
+632
+34% +$129K 0.39% 38
2025
Q2 		$349K Buy
1,879
+483
+35% +$89.8K 0.24% 56
2025
Q1 		$292K Buy
+1,396
New +$271K 0.19% 43

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LeConte Wealth Management's ABBV Position: Q1 2026 in Review

LeConte Wealth Management increased its AbbVie (ABBV) stake by 188% in Q1 2026, buying an estimated $1.04M and bringing the position to 7,173 shares worth $1.56M. The position accounts for 1.01% of the portfolio, ranked #21.

LeConte Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • LeConte Wealth Management held 7,173 shares of AbbVie worth $1.56M as of Q1 2026.
  • LeConte Wealth Management bought 4,686 AbbVie shares in Q1 2026, an estimated $1.04M.
  • AbbVie made up 1.01% of LeConte Wealth Management's portfolio in Q1 2026, its #21 holding.
  • LeConte Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.